Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody that binds to human programmed death ligand 2 (PD-L2) and uses thereof

Antibody that binds to human programmed death ligand 2 (PD-L2) and uses thereof

US Patent 10647771 · Granted May 12, 2020

Estimated economic value: $155,382,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MARCO antibodies and uses thereof2025
Multi-modal system for visualization and analysis of surgical specimens2025
Anti-TIGIT antibodies2024
Anti-LAG3 antibodies and antigen-binding fragments2024
Anti-TREM1 antibodies and related methods2024
Handheld multi-modal imaging device2024
Anti-TIGIT antibodies2024
Handheld endoscopic imaging device2024
Enhanced fused filament multi-color three-dimensional (3D) printing2023
Anti-MARCO antibodies and uses thereof2023
Antibody drug conjugate for anti-inflammatory applications2022
Antibodies binding to ILT42022